The Filing Desk

AbbVie vs Moderna

AbbVie ABBV · Moderna MRNA · Biotechnology

AbbVie reported revenue of $61.2 billion in fiscal 2025, 31.5 times Moderna's $1.9 billion in fiscal 2025. AbbVie's revenue grew 8.6% in its latest year, and Moderna's fell 39.9%. AbbVie had an operating margin of 24.6%, against -158.1% at Moderna. Free cash flow was $17.8 billion at AbbVie and −$2.1 billion at Moderna.

Side by side

AbbVieModerna
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$61.2B$1.9B
Revenue growth8.6%−39.9%
Revenue growth a year, last 5 years6.0%19.3%
Gross margin70.2%55.4%
Operating margin24.6%−158.1%
Net margin6.9%−145.2%
Free cash flow$17.8B−$2.1B
Free cash flow margin29.1%−106.2%
Return on capital15.7%−65.4%
Net debt to EBITDA2.7x—
Dividends and buybacks$12.6B$2M
Change in diluted share count0.0%1.3%
Last close$283.54$199.33
P/E at the last close48.8×—
Insider trades, last 12 monthssold $30.8 millionsold $98.5 million
Piotroski F-score7 of 92 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AbbVieModerna
Operating margin
Percent of revenue
AbbVieModerna
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AbbVieModerna

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AbbVie and Moderna pages.